BHCNYSEPharmaceutical PreparationsFiscal year ends December 31

Bausch Health Companies Inc.

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Jul 30, 2026

$6.32+0.02 (+0.32%)

Close on Oct 19, 2026

Community

Notes and questions about Bausch Health Companies from other investors

Discussion opens with sign-in. Posts will be able to point at any number on these pages, so everyone sees exactly which figure is being discussed.

Parsed from the XBRL in Bausch Health Companies's annual and quarterly filings with the SEC
Per-share figures adjusted for the 2-for-1 split on Oct 16, 2000
Fourth quarters derived from the annual report minus nine months
Every figure in the statements links to its source filing

Trailing twelve months. Peers are matched on business description, industry and size. Ticks are peers, the dot is BHC.

Revenue growth10.1% · median 2.9%

Operating margin8.1% · median 11.4%

Net margin-10.1% · median 27.5%

Advertisement
300 × 250